Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan · Delayed Price · Currency is TWD 54.40
-1.30 (-2.33%)
Apr 17, 2026, 1:30 PM CST
Oneness Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1,045 | -1,165 | -1,313 | 359.98 | -403.3 |
Depreciation & Amortization | 332.92 | 451.29 | 445.54 | 491.23 | 195.07 |
Other Amortization | 1.48 | 3.12 | 3.46 | 3.41 | 2.27 |
Loss (Gain) From Sale of Assets | -20.16 | 6.64 | -0.26 | - | - |
Asset Writedown & Restructuring Costs | - | 279.7 | - | 0.63 | -6.19 |
Loss (Gain) From Sale of Investments | 6.6 | 0.52 | 0.03 | -0.11 | -0.97 |
Loss (Gain) on Equity Investments | 253.9 | 428.9 | 498.78 | -90.02 | -280.31 |
Stock-Based Compensation | 27.87 | 29.31 | 44.43 | 20.34 | 21.71 |
Other Operating Activities | 53.39 | -329.94 | -96.74 | -697.48 | -228.9 |
Change in Accounts Receivable | -24.05 | 10.9 | -12.94 | 1.25 | 453.79 |
Change in Inventory | -5.44 | -1.34 | -19.35 | -31.42 | -31.13 |
Change in Accounts Payable | 0.87 | 0.31 | 0.29 | -0.33 | -39.22 |
Change in Unearned Revenue | -1.16 | -5.39 | 30.08 | -1,010 | - |
Change in Other Net Operating Assets | -41.68 | -54.45 | -2.63 | 71.02 | 28.29 |
Operating Cash Flow | -460.24 | -345.58 | -422.18 | -881 | -288.89 |
Capital Expenditures | -21.96 | -49.71 | -90.06 | -87.35 | -95.35 |
Sale of Property, Plant & Equipment | 1.85 | - | - | - | - |
Cash Acquisitions | - | -25.93 | - | - | - |
Sale (Purchase) of Intangibles | -4.53 | -1.17 | -0.86 | -1.84 | -4.95 |
Investment in Securities | 1,088 | 610.24 | -4,747 | 5,797 | 156.12 |
Other Investing Activities | 10.69 | 10.73 | 18.11 | 27.67 | 3.2 |
Investing Cash Flow | 1,077 | 544.16 | -4,820 | 5,736 | 59.54 |
Long-Term Debt Repaid | -43.02 | -35.56 | -14.22 | -13.38 | -24.58 |
Net Debt Issued (Repaid) | -43.02 | -35.56 | -14.22 | -13.38 | -24.58 |
Issuance of Common Stock | 30.52 | 55.27 | 257.01 | 344.12 | 516.25 |
Common Dividends Paid | - | - | -39.09 | - | - |
Other Financing Activities | - | -0.01 | 182.88 | 121.13 | -147 |
Financing Cash Flow | -12.49 | 19.7 | 386.58 | 451.87 | 344.67 |
Foreign Exchange Rate Adjustments | 6.9 | 16.64 | 12.89 | 15.44 | -0 |
Net Cash Flow | 610.97 | 234.93 | -4,842 | 5,322 | 115.32 |
Free Cash Flow | -482.21 | -395.28 | -512.23 | -968.35 | -384.24 |
Free Cash Flow Margin | -373.45% | -335.20% | -590.25% | -90.88% | -584.26% |
Free Cash Flow Per Share | -1.01 | -0.83 | -1.08 | -2.05 | -0.84 |
Cash Interest Paid | 8.9 | 9.61 | 5.61 | 4.6 | 4.9 |
Cash Income Tax Paid | 20.65 | 30.38 | 48.77 | 40.46 | 53.1 |
Levered Free Cash Flow | 104.58 | -320.32 | -359.3 | 381.75 | -44.2 |
Unlevered Free Cash Flow | 110.14 | -314.31 | -355.79 | 384.62 | -41.14 |
Change in Working Capital | -71.46 | -49.97 | -4.54 | -968.98 | 411.73 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.